These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10890947)

  • 41. Ultrasonic surgical aspiration with endoscopic confirmation for osmidrosis.
    Chung S; Yoo WM; Park YG; Shin KS; Park BY
    Br J Plast Surg; 2000 Apr; 53(3):212-4. PubMed ID: 10738326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The distribution, size and density of the apocrine glands in hidradenitis suppuritiva.
    Morgan WP; Hughes LE
    Br J Surg; 1979 Dec; 66(12):853-6. PubMed ID: 509057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Apocrine chromhidrosis].
    Schwarz T; Neumann R; Duschet P; Brückler B; Klein W; Oppolzer G; Bardach H; Gschnait F
    Hautarzt; 1989 Feb; 40(2):106-9. PubMed ID: 2714985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-fluence 585 nm Q-switched Nd:YAG laser: a novel laser treatment for post-acne erythema.
    Panchaprateep R; Munavalli G
    Lasers Surg Med; 2015 Feb; 47(2):148-55. PubMed ID: 25645645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
    Ustuner P; Balevi A; Ozdemir M
    J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Treatment of Axillary Odor: A Network Meta-Analysis.
    Sun P; Wang Y; Bi M; Chen Z
    Med Sci Monit; 2019 Apr; 25():2735-2744. PubMed ID: 30982056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outpatient thoracoscopic sympathicotomy for axillary osmidrosis.
    Hsia JY; Chen CY; Hsu CP; Shai SE; Yang SS; Chuang CY
    Eur J Cardiothorac Surg; 2003 Sep; 24(3):425-7. PubMed ID: 12965315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A case of apocrine adenocarcinoma associated with hamartomatous apocrine gland hyperplasia of both axillae.
    Nishikawa Y; Tokusashi Y; Saito Y; Ogawa K; Miyokawa N; Katagiri M
    Am J Surg Pathol; 1994 Aug; 18(8):832-6. PubMed ID: 8037297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of axillary osmidrosis using a laser with a 1,444-nm wavelength.
    Jeong JH; Hong JM; Pak CS; Kim JH; Heo CY
    Dermatol Surg; 2014 Aug; 40(8):851-7. PubMed ID: 25068545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimally invasive surgery for axillary osmidrosis: combined operation with CO2 laser and subcutaneous tissue remover.
    Kim IH; Seo SL; Oh CH
    Dermatol Surg; 1999 Nov; 25(11):875-9. PubMed ID: 10594601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Laser treatment of tattoos: a prospective, paired, comparison study of the Q-switched Nd:YAG (1064 nm), frequency-doubled Q-switched Nd:YAG (532 nm), and Q-switched ruby lasers.
    Goyal S; Arndt KA; Stern RS; O'Hare D; Dover JS
    J Am Acad Dermatol; 1997 Jan; 36(1):122-5. PubMed ID: 8996281
    [No Abstract]   [Full Text] [Related]  

  • 52. A comparison of two different sub-dermal trimming techniques for the treatment of axillary osmidrosis.
    Ding Z; Zheng J
    J Plast Reconstr Aesthet Surg; 2013 Nov; 66(11):1569-74. PubMed ID: 23890528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimizing treatment parameters for hair removal using a topical carbon-based solution and 1064-nm Q-switched neodymium:YAG laser energy.
    Nanni CA; Alster TS
    Arch Dermatol; 1997 Dec; 133(12):1546-9. PubMed ID: 9420539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effectiveness and safety of the improved mini-incision surgery for osmidrosis treatment.
    Zhang P; Li D; Li L; Pan S
    J Cosmet Dermatol; 2021 Dec; 20(12):3986-3990. PubMed ID: 33690951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apocrine Chromhidrosis.
    Shah A; Tsianou Z; Suchak R; Mann J
    Am J Dermatopathol; 2020 Oct; 42(10):e147-e148. PubMed ID: 32568832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of epidermal pigmented lesions with the frequency-doubled Q-switched Nd:YAG laser. A controlled, single-impact, dose-response, multicenter trial.
    Kilmer SL; Wheeland RG; Goldberg DJ; Anderson RR
    Arch Dermatol; 1994 Dec; 130(12):1515-9. PubMed ID: 7986124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 532-nm and 1064-nm Q-switched Nd:YAG laser therapy for reduction of pigmentation in macular amyloidosis patches.
    Ostovari N; Mohtasham N; Oadras MS; Malekzad F
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):442-6. PubMed ID: 18363913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimizing Q-switched lasers for melasma and acquired dermal melanoses.
    Aurangabadkar SJ
    Indian J Dermatol Venereol Leprol; 2019; 85(1):10-17. PubMed ID: 30027914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumescent liposuction with dermal curettage for treatment of axillary osmidrosis and hyperhidrosis.
    Lee D; Cho SH; Kim YC; Park JH; Lee SS; Park SW
    Dermatol Surg; 2006 Apr; 32(4):505-11; discussion 511. PubMed ID: 16681657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
    Gokalp H; Akkaya AD; Oram Y
    J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.